Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × cobimetinib × Clear all

Phase

Phase 2/3 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Melanoma 15 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Brain Neoplasms 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Xanthogranuloma, Juvenile 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Solid Tumors 1 Solid Tumor 1 Sarcoma, Clear Cell 1 Neoplasms, Unknown Primary 1 Microsatellite Unstable Colorectal Cancer 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Inflammatory Breast Neoplasms 1 Histiocytosis, Sinus 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Histiocytic Disorders, Malignant 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 34 fludarabine 29 Tacrolimus 25 Whole-Body Irradiation 22 Mycophenolic Acid 22 Busulfan 21 fludarabine phosphate 19 Melphalan 16 thymoglobulin 14 Antilymphocyte Serum 14 Thiotepa 11 Methotrexate 11 Stem Cell Transplantation 8 Sirolimus 7 Rituximab 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 trametinib 5 ruxolitinib 4 merphos 4 Nivolumab 4 Cytarabine 4 Cyclosporine 4 Cord Blood Stem Cell Transplantation 4 fedratinib 3 ceritinib 3 angiotensin I (1-7) 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Pentostatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡